AMARIN CORP PLC\UK Debt Instrument, Redemption Price, Percentage
AMARIN CORP PLC\UK (AMRN) reported Debt Instrument, Redemption Price, Percentage of 100.00% for the 1-month period ending 2012-01-31, per its 10-Q filed 2014-05-09.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentRedemptionPricePercentage · last filed 2014-05-09
- 2012-01-31: Debt Instrument, Redemption Price, Percentage 1 month 100.00%.
| Period end | Debt Instrument, Redemption Price, Percentage 1 month |
|---|---|
| 2012-01-31 | 100.00% 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |